Latest / Pharmacy Podcast Network / Accessing Accurate Drug Information | phactMI: Empowering Healthcare Decisions
Transcript
- 0:06Speaker 1: As you are listening to the Pharmacy podcast Network.
- 0:14Speaker 2: Hi, this is John Stills Miller, CEO of fact Demi,
- 0:18Speaker 2: and this is the fact of my podcast series. The
- 0:23Speaker 2: achievements of any organization are the results of the combined
- 0:26Speaker 2: efforts of every individual. Fact Demi was established in twenty
- 0:31Speaker 2: fourteen to increase awareness and enhance access to relevant and
- 0:35Speaker 2: evidence based drug information. This is the same mission that
- 0:39Speaker 2: drives fact Demi. Today. Happy ten year anniversary to fact Demi.
- 0:44Speaker 3: Our host, Evelyn DeSantis talks with medical information experts about
- 0:48Speaker 3: the challenges of keeping up to date with drug info,
- 0:51Speaker 3: consequences on misinformation and healthcare and medical information as a resource,
- 0:56Speaker 3: and the people behind this data from the pharmaceutical industry insiders.
- 1:00Speaker 4: Welcome back to the fact am I podcast series. This
- 1:04Speaker 4: is episode three in our series of four. So if
- 1:08Speaker 4: you haven't listened episode one and two, you will find
- 1:12Speaker 4: the links to the show note in our show notes
- 1:15Speaker 4: to episode one and two. And if you're driving, if
- 1:18Speaker 4: you're walking and jogging, don't worry. Just go to any
- 1:21Speaker 4: of your favorite podcast apps and directories Apple, Spotify and
- 1:26Speaker 4: you'll find the entire series throughout the latest episodes that
- 1:32Speaker 4: we're publishing We're also going to have a place on
- 1:34Speaker 4: fact m I to not only get the entire series,
- 1:38Speaker 4: but also access more information. Evelyn, welcome back. I can't
- 1:43Speaker 4: believe how fast this is going. It's all exciting. It's
- 1:46Speaker 4: always exciting to talk with you.
- 1:48Speaker 5: Thanks so much, Todd. It is exciting to talk to
- 1:50Speaker 5: you as well. And I can't believe we're on episode
- 1:53Speaker 5: three already.
- 1:54Speaker 6: This has been great.
- 1:55Speaker 4: So just for the listeners, we were really jumping into
- 1:59Speaker 4: the power of act drug information and episode one great
- 2:02Speaker 4: conversation that you really staged and you were able to
- 2:07Speaker 4: pull through some of the guest insights. Episode two was
- 2:10Speaker 4: breaking into drug information equally interesting things in there that
- 2:16Speaker 4: I had never heard of. So listeners, if you want
- 2:20Speaker 4: and understanding the transition from practice the industry, definitely listen
- 2:23Speaker 4: to that episode. Now we're accessing accurate drug information evil
- 2:27Speaker 4: and I think of our pharmacists out there in all
- 2:30Speaker 4: settings we're thinking of rare disease and long term care,
- 2:33Speaker 4: geriatrics are pediatrics, and that accurate and being able to
- 2:38Speaker 4: access this information is so important. I'm going to turn
- 2:41Speaker 4: it over to you to welcome our guests and get
- 2:43Speaker 4: us started once again accessing accurate drug information with fact AM.
- 2:48Speaker 5: I thanks so much, Ton, and Yeah, I have to
- 2:51Speaker 5: just underscore how important that accessing information is.
- 2:56Speaker 6: You know, when I was.
- 2:57Speaker 5: A faculty member, that was the one thing I always
- 2:59Speaker 5: taught to student was that you didn't have to memorize
- 3:03Speaker 5: everything off the top of your head or know everything
- 3:05Speaker 5: off the top of your head.
- 3:06Speaker 6: You just had to know where to find it.
- 3:09Speaker 5: So I think really being able to dig into that
- 3:12Speaker 5: today is going to.
- 3:14Speaker 6: Be helpful for practitioners in every venue.
- 3:18Speaker 5: So I'd really like to thank our panelists today for
- 3:20Speaker 5: being able to share their stories.
- 3:22Speaker 6: So we have in Johnny Carr, who.
- 3:25Speaker 5: Is at the University Hospital Health System in Cleveland, Ohio,
- 3:31Speaker 5: Dana Vasia who is at the Ernest Mario School of
- 3:34Speaker 5: Pharmacy Rutgers at the State University of New Jersey, and
- 3:38Speaker 5: Jen Riggins who is at FACT DEMAI.
- 3:41Speaker 6: So, guys, thank you so very much for joining us today.
- 3:46Speaker 6: If we could just.
- 3:47Speaker 5: Go through and just share briefly about what your current role.
- 3:51Speaker 6: Is, that would be great. And Johnny, why don't we
- 3:54Speaker 6: start with you?
- 3:56Speaker 7: Sure?
- 3:57Speaker 8: Thanks, eveln Hi, everybody, I'm in Johnny Carr. I manage
- 4:01Speaker 8: formulary and policy at University hospitals. We're a sixteen hospital
- 4:05Speaker 8: health system in northeast Ohio. So all things from our
- 4:08Speaker 8: adult and pediatric system formula processes, to working with our
- 4:13Speaker 8: physician offices and ambulatory spaces for med management oversight, and
- 4:17Speaker 8: all things policy for drug related needs.
- 4:20Speaker 9: So lots of needs for drug information in my role
- 4:25Speaker 9: all great, Dan, How.
- 4:27Speaker 7: About yourself, thanks again Evlin for having me.
- 4:31Speaker 10: So, as you mentioned, I'm with the Ernest Marri School
- 4:34Speaker 10: of Pharmacy, a clinical associate professor there in drug information
- 4:39Speaker 10: and medication safety, and so.
- 4:41Speaker 7: Currently I direct place that.
- 4:44Speaker 10: You very well know, the now called the meduth Safety
- 4:48Speaker 10: and Information Center, the Legacy Drug Information Center here at
- 4:50Speaker 10: Rutgers and Robert Johnson Barnabas Health you know, where we
- 4:55Speaker 10: provide information of all kinds to.
- 4:59Speaker 7: Both the the school and the state of New Jersey.
- 5:02Speaker 10: In my role, I serve as a preceptor for medication
- 5:09Speaker 10: information fellows from Johnson and Johnson. Also the program director
- 5:13Speaker 10: for a PG Y two Medication Use, Safety and Policy
- 5:16Speaker 10: residency program that is based here in New Brunswick, New Jersey.
- 5:21Speaker 10: And we have you know, countless numbers of students that
- 5:26Speaker 10: rotate through learning you know, practices of drug information and
- 5:29Speaker 10: now med safety and so besides large teaching component that
- 5:33Speaker 10: I have, you know, responsible for overseeing not only the
- 5:38Speaker 10: drug information portion, but assisting both the hospital local P
- 5:42Speaker 10: and T and are now system formulary committee with formulary
- 5:46Speaker 10: management practices, med use policy, and medication safety practices.
- 5:51Speaker 11: Well dah, that sounds a lot And yes, I had
- 5:56Speaker 11: been at Rutgers as a faculty vebrod ran what you
- 6:00Speaker 11: to be the Drug Information Service, but it sounds like
- 6:03Speaker 11: you really are taking it to that next level.
- 6:06Speaker 5: Jen, I wanted to bring you in as well. Why
- 6:09Speaker 5: don't you introduce yourself?
- 6:11Speaker 6: Yeah, thank you.
- 6:11Speaker 4: Hi.
- 6:12Speaker 1: I'm Jennifer Riggins and I have had a long career
- 6:16Speaker 1: in the pharmaceutical industry in medical information and about three
- 6:21Speaker 1: years ago joined the FACT in my organization as the
- 6:24Speaker 1: partnership and technology strategists and so I work to develop
- 6:29Speaker 1: partnerships with other third party organizations that we're trying to
- 6:34Speaker 1: get our tools and technology in partnership with, so working
- 6:38Speaker 1: with healthcare associations, pharmacy organizations, EMRs, those types of groups.
- 6:47Speaker 6: So we're looking at doing some great.
- 6:49Speaker 5: Partnerships, wonderful and we will definitely be digging into that
- 6:55Speaker 5: technology a little bit later in the podcast, So really
- 6:59Speaker 5: just start with I want to, you know, kind of
- 7:02Speaker 5: pick your brains both in Johnny and Dan about what
- 7:06Speaker 5: have been some of the real world examples that you
- 7:09Speaker 5: have based and challenges on finding accurate information to help
- 7:15Speaker 5: you navigate the various situations in healthcare that you face.
- 7:20Speaker 9: A lot of these scenarios we run into our off
- 7:24Speaker 9: label needs or things that may not have a lot
- 7:27Speaker 9: of information published, but we'll take anything we can get,
- 7:32Speaker 9: even case reports or case series or information that our
- 7:36Speaker 9: pharmaceutical company colleagues have not published but are available when
- 7:42Speaker 9: we call our med insult lines. So one of the
- 7:45Speaker 9: examples to examples I'll go through recently that we dealt with.
- 7:49Speaker 9: We're thinking through biosimilars all the time, good cost saving opportunity,
- 7:53Speaker 9: good thing to look at from a formulae standpoint, and
- 7:57Speaker 9: when we're trying to understand the usability of a bio
- 8:00Speaker 9: similar there may not be many clinical studies. That's not
- 8:03Speaker 9: how they're approved through the normal FDA process. There may
- 8:07Speaker 9: only be one indication that's clinically studied, but there may
- 8:10Speaker 9: not be in other areas. And so when we're evaluating
- 8:14Speaker 9: for our pediatric patients, we really need to dig into
- 8:17Speaker 9: the PK and PD information to help us understand if
- 8:21Speaker 9: it's appropriate in those patients. So that's something that I've
- 8:25Speaker 9: really looked for data on and we've had to call
- 8:29Speaker 9: for that information in the past because it's not always
- 8:33Speaker 9: published on.
- 8:34Speaker 6: The FDA site.
- 8:35Speaker 9: That's usually my first go to for information, but then
- 8:39Speaker 9: we also will call the met info lines, which have
- 8:42Speaker 9: been very helpful through that kind of information. The other
- 8:46Speaker 9: scenario we ran into was when we were evaluating the
- 8:49Speaker 9: new RSV vaccine for our maternal patients, the abrismo vaccine
- 8:54Speaker 9: compared to nursevamaps, So any babies who received the nursevamab
- 8:58Speaker 9: and if mom needs a as well, and what does
- 9:00Speaker 9: that look like and what's the information around that. So
- 9:04Speaker 9: that was something that was published in a lot of
- 9:07Speaker 9: different areas, like information from ASIP and CDC as well
- 9:11Speaker 9: as a lot of company content that helped us implement
- 9:15Speaker 9: both products last season, and even better, we have more.
- 9:19Speaker 12: Information for this season, which is helpful. So those are
- 9:22Speaker 12: two examples of things where we've had to gather information
- 9:26Speaker 12: in I think very different ways, and it just shows
- 9:29Speaker 12: that content is available, you have to know where to
- 9:32Speaker 12: find it, like you said, as well as what to.
- 9:35Speaker 9: Ask when you can't find something, and that usually gets
- 9:38Speaker 9: us further down the road.
- 9:43Speaker 5: That's great, thank you, And I think those are two
- 9:46Speaker 5: great examples of where, you know, the way that we
- 9:50Speaker 5: normally find information works probably about eighty percent of the time,
- 9:55Speaker 5: but it's that other twenty percent that we really need
- 9:58Speaker 5: to dig in and figure out how else we can
- 10:01Speaker 5: find that information and being able to realize what are
- 10:05Speaker 5: some of those resources, like being able to use the
- 10:08Speaker 5: pharmaceutical medical information contact centers as one aspect, Dan.
- 10:14Speaker 6: How about you?
- 10:15Speaker 10: Yeah, I like how and Ronnie said, getting further down
- 10:20Speaker 10: the path because it very much is the journey versus
- 10:24Speaker 10: the destination.
- 10:25Speaker 7: Because I think all of us you know today can.
- 10:28Speaker 10: Understand that that it's very hard to get always that
- 10:32Speaker 10: exact answer that we want and find that exact piece
- 10:35Speaker 10: of information. You know, I'm sure all of us have shared.
- 10:38Speaker 7: At times with our learners.
- 10:40Speaker 10: You know, be comfortable, especially when you're in this setting,
- 10:43Speaker 10: be comfortable in the gray area, because that is, you know,
- 10:45Speaker 10: definitely where we like to navigate.
- 10:47Speaker 7: The black and white is, especially the questions we get,
- 10:52Speaker 7: it's often not there. And because we now live in
- 10:55Speaker 7: a world where getting that black and.
- 10:56Speaker 10: White information generally is easier than it has been, you know,
- 11:00Speaker 10: for me in terms of real world examples. One area
- 11:03Speaker 10: that we the number of questions from our call center
- 11:08Speaker 10: and electronic request system that we receive most commonly at
- 11:13Speaker 10: our location at least fifty percent of the time, if
- 11:16Speaker 10: not close to sixty are questions related to a very
- 11:20Speaker 10: unique allergy, alphagal syndrome, right.
- 11:24Speaker 7: The mammalian meat allergy.
- 11:25Speaker 13: And I think some of us discussing, you know, we
- 11:30Speaker 13: I'm only chuckling because it is kind of taken over
- 11:33Speaker 13: this this this center that I and my team, but
- 11:37Speaker 13: you know, being a relatively rare condition that is evolving,
- 11:42Speaker 13: and you know, as we especially over the past year
- 11:44Speaker 13: that CDC now recognizes as a threat as a vector
- 11:48Speaker 13: borne illness that can translate into this allergy, there's not
- 11:52Speaker 13: a lot of information about not only just what causes it,
- 11:56Speaker 13: but especially from our standpoint, what's contained in inactive ingredients
- 12:01Speaker 13: within medications that could.
- 12:03Speaker 7: Then elicit a an allergic response. And so.
- 12:08Speaker 10: Every week we are contacting medication medical information centers throughout
- 12:13Speaker 10: the country and throughout the world, you know, updating a
- 12:16Speaker 10: database that we have and really you know, leaning on
- 12:20Speaker 10: those resources from from the industry because sourcing ingredients and
- 12:24Speaker 10: that information is not readily available both you know, from
- 12:27Speaker 10: the company, isn't even through the FDA, and so you know,
- 12:31Speaker 10: that's one area in particular that we struggle with. But
- 12:35Speaker 10: having resources like fat Demi and other areas where we
- 12:38Speaker 10: could directly interface has been a huge help.
- 12:42Speaker 7: The other piece is is, you know, drug shortages and.
- 12:47Speaker 10: Navigating not necessarily the shortage itself, that's generally a parent
- 12:52Speaker 10: but now, what do we do right if we have
- 12:55Speaker 10: a product that we cannot get and we need to
- 12:57Speaker 10: manage our patients in other ways? Is how do we
- 13:01Speaker 10: quickly get information that will support use of another product
- 13:05Speaker 10: or another agent in the same.
- 13:07Speaker 7: Class or another class.
- 13:08Speaker 10: And so those are areas I'd say over the past year,
- 13:12Speaker 10: certainly I have you know, needed accurate information quickly.
- 13:21Speaker 6: I think those are also some great examples.
- 13:23Speaker 5: But actually I want to dig back onto something you
- 13:26Speaker 5: said about being able to find you know, a lot
- 13:28Speaker 5: of times the answers are not just black and white
- 13:32Speaker 5: for what you as a drug information specialist get and
- 13:35Speaker 5: when in Johnny gets, but for a lot of healthcare
- 13:39Speaker 5: professionals and a lot of pharmacists sometimes the answer is just.
- 13:42Speaker 6: In the label. And you know, we all know what
- 13:45Speaker 6: those labels look like.
- 13:47Speaker 5: We know how difficult it is to sometimes read through
- 13:52Speaker 5: the entire package insert to find that information. So a
- 13:55Speaker 5: lot of times, just even the black and white answers
- 13:59Speaker 5: can sometimes get a little bit more. I'm consuming to
- 14:03Speaker 5: find the full information. But you're right, you know, when
- 14:08Speaker 5: we get into those more oddball cases, are I guess
- 14:13Speaker 5: used to be oddball, but now it sounds like fifty
- 14:15Speaker 5: to sixty sounds like a majority of your questions, And
- 14:18Speaker 5: as the legacy director, I'm sorry, but you know, no harm.
- 14:25Speaker 7: There are times that you know you're wondering, well I
- 14:28Speaker 7: ever get a question that's not alphagat related.
- 14:30Speaker 10: But in the end, we are helping out a lot
- 14:32Speaker 10: of people throughout the country, which is pretty cool.
- 14:35Speaker 5: And that's one of the things I always thought that
- 14:37Speaker 5: was really cool about that was you know, you've become
- 14:40Speaker 5: the expert and are helping not only patients but pharmacists
- 14:46Speaker 5: who get that type of question and are you know,
- 14:49Speaker 5: they don't know where to turn next, so it's.
- 14:52Speaker 6: Great that they can turn to you.
- 14:55Speaker 14: Jen.
- 14:56Speaker 6: I want to bring you in on this as well.
- 14:59Speaker 6: You've been with fact.
- 15:00Speaker 5: Mine now for a little bit, for a little while,
- 15:03Speaker 5: can you provide us some of the historical perspective on
- 15:06Speaker 5: the evolution of the drug Information.
- 15:09Speaker 6: Portal as a resource on factomie.
- 15:12Speaker 14: Yeah.
- 15:12Speaker 1: Absolutely, And I think, you know, just to bring it
- 15:16Speaker 1: full circle with some of the examples that Dan and
- 15:20Speaker 1: Johnny have talked about here is we started out with
- 15:24Speaker 1: this thinking.
- 15:25Speaker 6: About how could we.
- 15:28Speaker 1: Bring together the resources that would be helpful to healthcare
- 15:33Speaker 1: professionals as they're trying to answer questions and so being
- 15:37Speaker 1: able to pull together all of those company contact center information,
- 15:43Speaker 1: you know, how do I get a hold of company X,
- 15:46Speaker 1: How do I get a hold of Company Y? What
- 15:48Speaker 1: are the all of the phone numbers, the chat services,
- 15:54Speaker 1: the websites? Can I get all of those in one
- 15:57Speaker 1: single location so that I don't have to keep looking
- 16:01Speaker 1: and searching for how to get a hold of this
- 16:03Speaker 1: particular company.
- 16:04Speaker 6: And so, as we were thinking.
- 16:06Speaker 1: About what would be a great one stop shop website
- 16:10Speaker 1: or a drug information portal which we now today are
- 16:14Speaker 1: calling the Drug Information Database, those things were major elements
- 16:19Speaker 1: of our strategy back in twenty thirteen when we started
- 16:23Speaker 1: ideating around.
- 16:24Speaker 6: What this could look like.
- 16:26Speaker 1: So there were nineteen pharma companies that came together and
- 16:30Speaker 1: started creating this what would be this drug information database.
- 16:35Speaker 1: We started thinking about how could we get the information
- 16:42Speaker 1: and the format and the channel preferences that hdps would
- 16:45Speaker 1: want and be able to provide this information to them.
- 16:48Speaker 6: So we used a phased approach.
- 16:50Speaker 1: We started with that common database of all the ways
- 16:54Speaker 1: to reach an individual pharma company medical information team.
- 16:57Speaker 6: I just wanted to add in the back. I'm twenty thirteen.
- 17:01Speaker 5: When you guys put together that list of how to
- 17:06Speaker 5: access not only the phone numbers, but at that point,
- 17:10Speaker 5: the up and coming websites that the drug information the
- 17:15Speaker 5: medical information departments were putting out there. As a drug
- 17:21Speaker 5: information specialist, as a faculty member.
- 17:24Speaker 6: I was, you know, singing those praises.
- 17:29Speaker 5: That's what first got me, you know, acquainted with the
- 17:34Speaker 5: fact of my website, and I just thought that was
- 17:38Speaker 5: an amazing resource and I just had to put it
- 17:41Speaker 5: out there.
- 17:42Speaker 6: You know, we could find I could find the telephone
- 17:44Speaker 6: numbers pretty easily, there were different places.
- 17:47Speaker 5: It was nice to have them all in one place,
- 17:50Speaker 5: But to find those med info websites, that was an
- 17:54Speaker 5: answer to prayer.
- 17:55Speaker 6: I just needed to throw that in there.
- 17:57Speaker 1: Yeah, I'm glad you added that, I think that that's
- 18:01Speaker 1: a great comment to hear, because I think it has
- 18:04Speaker 1: been really useful. So that's how we started. We put
- 18:07Speaker 1: those pieces of critical information together first and foremost, and
- 18:11Speaker 1: we got that out, and then we started to add
- 18:14Speaker 1: package labels and so for all of our member companies
- 18:17Speaker 1: products as well as every product that's been approved by
- 18:21Speaker 1: the FDA. Eventually we have made all of those available
- 18:25Speaker 1: through the fact of my Drug Information Portal so that
- 18:30Speaker 1: they're searchable. All of those package labels are searchable and
- 18:35Speaker 1: you can.
- 18:35Speaker 14: Find those black and white answers that you were looking
- 18:39Speaker 14: for and that we've talked about earlier as well as
- 18:43Speaker 14: then in the next phases, we've started adding scientific responses,
- 18:47Speaker 14: so answers to questions that each of these companies received
- 18:51Speaker 14: frequently about the products that they market, and making those
- 18:57Speaker 14: available in a searchable format as well.
- 19:00Speaker 1: So I think those are really the big pieces that
- 19:03Speaker 1: are a part of the Drug Information Portal, and I
- 19:06Speaker 1: think the next step that we'll be thinking about then
- 19:09Speaker 1: is how do we bring patient information on board here?
- 19:12Speaker 1: And as companies are making those resources available more and more,
- 19:17Speaker 1: we'll have both HDP information as well as patient information
- 19:21Speaker 1: available through this website.
- 19:24Speaker 5: That's great, Jen, and I'm so appreciative of all the
- 19:28Speaker 5: advances that we've been able to do with that.
- 19:33Speaker 6: Dan, I'm going to throw it back to you.
- 19:35Speaker 5: Have you been able to utilize anything on that portal
- 19:40Speaker 5: for responding to any of the questions.
- 19:42Speaker 10: That you get face with Ye, yes, I have, and
- 19:46Speaker 10: really in two major ways. Number One, as just an
- 19:49Speaker 10: actual resource to get information.
- 19:51Speaker 7: It's been helpful when you know, kind.
- 19:55Speaker 10: Of an off maybe off label questions come up regarding
- 20:00Speaker 10: product and getting not just alpha gel you know, whether
- 20:02Speaker 10: it's stability information or you know, adverse effect.
- 20:08Speaker 7: That is one of the places that we will go,
- 20:09Speaker 7: especially when.
- 20:10Speaker 10: We're like leaning towards needing information from the manufacturer. So
- 20:14Speaker 10: so to answer, yes, I certainly use it, and I'm
- 20:18Speaker 10: trying to share that with our with our learners, And
- 20:21Speaker 10: that's really the other piece is using it as a
- 20:24Speaker 10: teaching tool to to share about other sources of accurate
- 20:30Speaker 10: referenced information regarding drugs and to assist you know, soon
- 20:36Speaker 10: to be pharmacists or actual pharmacists so soon to be
- 20:39Speaker 10: clinicians in in this practice and just their day to
- 20:42Speaker 10: day activities. So it's been really a helpful resource into
- 20:47Speaker 10: your getting the history has been helpful to know, you know,
- 20:51Speaker 10: really where.
- 20:51Speaker 7: We've gone and understanding.
- 20:53Speaker 15: I think a big piece is that we often say
- 20:55Speaker 15: we collectively forget that, you know, our pharma partners have
- 21:01Speaker 15: quite a bit of information on their products, and having
- 21:04Speaker 15: kind of a one stop shop is really nice to
- 21:07Speaker 15: know and share with other practitioners.
- 21:10Speaker 1: Just to add into that, I think it's great that
- 21:14Speaker 1: you're using starting to use this as a teaching tool.
- 21:17Speaker 1: I think awareness is a big area where we need
- 21:21Speaker 1: to put some efforts around increasing awareness of resources that
- 21:28Speaker 1: pharmacists and other healthcare providers can access to get drug
- 21:33Speaker 1: information questions answered.
- 21:35Speaker 6: And so as we.
- 21:37Speaker 1: Hit those pharmacy students and medical students, etc. And make
- 21:41Speaker 1: them aware of the resources that are available to them
- 21:44Speaker 1: such as the Drug Information Database or even drug information
- 21:47Speaker 1: centers themselves in being able to get answers to the questions,
- 21:52Speaker 1: I think it really benefits patients in the long run.
- 22:01Speaker 9: The Gem's point, I've used the portal mainly as a
- 22:05Speaker 9: teaching tool so far. A lot of questions I end
- 22:08Speaker 9: up having for now are with manufacturers that are not
- 22:14Speaker 9: in fact am I yet.
- 22:15Speaker 6: But I'm really happy.
- 22:16Speaker 9: To hear that it's continuing to expand and has more
- 22:20Speaker 9: companies involved, because that will make it even more usable
- 22:24Speaker 9: as we continue to use it. But I've used it
- 22:26Speaker 9: as a teaching tool with my students and my residents
- 22:29Speaker 9: as another resource, another place for us to utilize when
- 22:33Speaker 9: we have questions and trying to navigate, because we have
- 22:38Speaker 9: to face it, there are more pharmaceutical companies than there
- 22:41Speaker 9: are individual pharmacists taking care of patients. In terms of
- 22:46Speaker 9: products that are out there, there's NonStop information that we
- 22:50Speaker 9: are having to navigate to find and then digest. So
- 22:54Speaker 9: having a place that helps to do that, in addition
- 22:57Speaker 9: to many other resources that we need to teach to
- 23:00Speaker 9: and use and be proficient in, is very useful.
- 23:09Speaker 6: I agree.
- 23:10Speaker 5: And knowing that there's a place, you know one you
- 23:13Speaker 5: can get that in depth information and kind of the
- 23:16Speaker 5: stuff that only the manufacturer has in those scientific response documents,
- 23:21Speaker 5: but also knowing it has all of the package inserts,
- 23:25Speaker 5: so and searchable with a layout that as I've played
- 23:31Speaker 5: with it, I think can actually be an easier way
- 23:34Speaker 5: of getting some of that label information than some of
- 23:37Speaker 5: the other resources out there.
- 23:41Speaker 6: Jen, I wanted to just circle back.
- 23:44Speaker 5: On something you said earlier about kind of where the
- 23:48Speaker 5: drug information portal.
- 23:49Speaker 6: From fact Tom, I maybe going you mentioned a.
- 23:52Speaker 5: Little bit about getting some patient information on there. You
- 23:56Speaker 5: want to expand upon that a little bit.
- 23:59Speaker 1: Yeah, So we feel like that as the consumer becomes
- 24:04Speaker 1: more and more engaged in championing their own healthcare, they're
- 24:10Speaker 1: seeking information and we want them to have access to
- 24:15Speaker 1: as many credible sources of information as possible. And many
- 24:20Speaker 1: of the medical information groups are starting to be providers
- 24:24Speaker 1: of some of that information to patients, along with obviously
- 24:29Speaker 1: the brand teams.
- 24:30Speaker 6: And that sort of thing. But there are a number of.
- 24:33Speaker 1: Questions, just like healthcare professionals have, that consumers have directly
- 24:37Speaker 1: to the pharma companies, and so we're working to make
- 24:41Speaker 1: those resources available in plane language, easy to digest information
- 24:48Speaker 1: that helps a patient better understand a product that they
- 24:54Speaker 1: may be taking, or perhaps a disease state or a
- 24:57Speaker 1: disease state and product combination.
- 24:59Speaker 5: I think that's great, and I think that also kind
- 25:02Speaker 5: of as we continue to build that awareness, it's a
- 25:05Speaker 5: place where healthcare professionals can go to get information to
- 25:10Speaker 5: be able to give to their patients, so not just
- 25:14Speaker 5: from accessing it as a patient, but actually accessing it
- 25:18Speaker 5: as a pharmacist.
- 25:20Speaker 6: When a patient asks you the question, you know potentially
- 25:23Speaker 6: you can go there.
- 25:24Speaker 5: You could point them there, You could go there yourself
- 25:27Speaker 5: and be able to get them that level of information.
- 25:33Speaker 5: Knowing that fact, my Drug Information Portal is one of
- 25:38Speaker 5: the resources available. Throwing this back to both Dana and
- 25:44Speaker 5: ANDRONI what would your most salient piece of advice for
- 25:49Speaker 5: accessing drug information be?
- 25:55Speaker 9: I think Dan and I covered this, but it is
- 25:58Speaker 9: worth repeating something I'm sure all of us have taught
- 26:03Speaker 9: our own students and residents. Doctor d taught me this
- 26:06Speaker 9: when I was one.
- 26:07Speaker 6: Of her residents.
- 26:09Speaker 9: Depending on the question, you have to know the first source.
- 26:14Speaker 6: That you're going to navigate to, and.
- 26:17Speaker 9: Then, after you've navigated to a resource that you know
- 26:21Speaker 9: will get you the majority of whatever question you're dealing with,
- 26:24Speaker 9: what are those next levels that you'll work down towards.
- 26:28Speaker 6: Many times we.
- 26:29Speaker 9: Don't have resources that answer all of our questions. Many
- 26:33Speaker 9: times we do, but sometimes we don't, and we have
- 26:35Speaker 9: to know about the content we're looking for and try
- 26:39Speaker 9: to navigate to those resources.
- 26:41Speaker 6: I think that's the main thing that.
- 26:43Speaker 9: Has helped me along the way, knowing my sources of
- 26:46Speaker 9: truths and going after.
- 26:48Speaker 7: Them yeah, I agree with Johnny.
- 26:54Speaker 10: Those having those sources of truth are our key, right,
- 26:58Speaker 10: and I think a lot of us have learned earned
- 27:00Speaker 10: as we went through our schooling and training to start
- 27:02Speaker 10: building that library, if you will, you know, early on,
- 27:05Speaker 10: I think all of us can, probably me, you know,
- 27:07Speaker 10: go through a list of what our sources of truth
- 27:09Speaker 10: are initially, so wholeheartedly agree, and I think now as
- 27:14Speaker 10: I think about this question, Evelyn, is you know in this.
- 27:18Speaker 16: As we see AI to you know, not take over yet,
- 27:23Speaker 16: I hope become more of a part of our professional
- 27:27Speaker 16: lives and personal lives.
- 27:29Speaker 10: It's so easy to get information. I mean it has
- 27:31Speaker 10: been right with internet access, but even more so to
- 27:35Speaker 10: prompt something to get the information that that you're seeking.
- 27:39Speaker 10: It's even more important that I kind of take the
- 27:42Speaker 10: advice of my father right and just building something to
- 27:45Speaker 10: you know, a project which is measured twice cut once.
- 27:48Speaker 10: It's still not only knowing the source, as a Johnny's point,
- 27:51Speaker 10: but checking at least two of them before giving a response.
- 27:54Speaker 7: Again, it's so tempting to type prompt into chat, GPT.
- 27:58Speaker 10: Or perplexity or whatever you preferences and get a resource
- 28:03Speaker 10: and then give that information because it's quick, but really
- 28:07Speaker 10: making sure that we understand that this, you know, it
- 28:10Speaker 10: is a source of truth, and making sure we're giving
- 28:13Speaker 10: accurate information, especially in this day and age where information
- 28:16Speaker 10: is needed quicker and quicker seemingly every day.
- 28:21Speaker 5: And to just add on to that, you know, not
- 28:25Speaker 5: only is information needed, we're running not only the twenty
- 28:29Speaker 5: four hour news cycle, but healthcare runs twenty four hours,
- 28:34Speaker 5: so needs are twenty four hours. So yeah, so having
- 28:38Speaker 5: a place that you can access we want that information
- 28:42Speaker 5: faster and faster. Yes, I think AI has opportunities.
- 28:49Speaker 6: But knowing that it can.
- 28:51Speaker 5: Pull from the universe of data, I think that also
- 28:56Speaker 5: leads us into probably a whole other series.
- 29:01Speaker 6: Of podcast topics.
- 29:05Speaker 5: Disinformation and disinformation that's out there. You know, the FDA's
- 29:09Speaker 5: recent guidance on allowing companies now to be able to
- 29:14Speaker 5: address that misinformation, and you know, part of that whole
- 29:18Speaker 5: guidance is understanding the difference between opinion and personal experience,
- 29:24Speaker 5: which everybody has their right to, but then providing misinformation.
- 29:30Speaker 5: I think that is just something to understand that is
- 29:34Speaker 5: so critical. And yeah, I one of the things that
- 29:39Speaker 5: I always taught and I'm sure you teach and drawn
- 29:42Speaker 5: he teaches and echoed that you look into places. You
- 29:49Speaker 5: look one place, you get one answer, you get one opinion,
- 29:52Speaker 5: but you need to double check that and look into
- 29:55Speaker 5: because we have so often We've seen this time and
- 29:59Speaker 5: time again with some of my go to resources when
- 30:02Speaker 5: I was in practice had one answer, but then you
- 30:06Speaker 5: look somewhere else and it was a different answer.
- 30:09Speaker 6: So then you're left going, Okay.
- 30:12Speaker 5: Why do these two well established resources tell me something different?
- 30:19Speaker 5: So I think being able to check multiple places is
- 30:22Speaker 5: so so important and knowing what those accurate resources are.
- 30:27Speaker 5: We all have those go to you know, tertiary compendiums
- 30:32Speaker 5: that we go to all the time, and I think
- 30:35Speaker 5: hopefully being able to add the fact to my portal
- 30:39Speaker 5: into that your go to resources for labeled information, but
- 30:44Speaker 5: then also for those scientific response documents, can just you know,
- 30:49Speaker 5: increase your toolkit. As we start to close out this podcast,
- 30:56Speaker 5: I just wanted to review some of the key takeaways
- 31:01Speaker 5: based on our conversation to make sure we hit the
- 31:04Speaker 5: objectives laid out for this podcast. So we have discussed
- 31:08Speaker 5: some real world challenges and how information helped navigate those situations.
- 31:14Speaker 5: Both in Johnny and Dan, you gave some great examples
- 31:18Speaker 5: of that being everything from understanding issues coming up from
- 31:23Speaker 5: formulary to answering patient specific questions with allergies and stability information.
- 31:32Speaker 5: And we also described how to access the information from
- 31:36Speaker 5: the fact to my Drug Information Portal that that is
- 31:39Speaker 5: just on the website. A couple of clicks, you're into
- 31:43Speaker 5: the portal, identifying yourself as a pharmacist or healthcare professional,
- 31:49Speaker 5: and then really being able to select a drug or
- 31:53Speaker 5: type in a drug drug name, and then being able
- 31:57Speaker 5: to type in a question to being able to act
- 32:00Speaker 5: us that you know information, whether it's again the label
- 32:04Speaker 5: information or a response document information. With that, I would
- 32:10Speaker 5: like to just again thank you guys so much for
- 32:13Speaker 5: your time today and throw it.
- 32:16Speaker 6: Back to you Toad.
- 32:19Speaker 4: All right, Evelyn, thank you so much. What an interesting conversation.
- 32:23Speaker 4: This is the third part of our podcast series Empowering
- 32:27Speaker 4: Healthcare Decisions. Today's discussion was around accessing accurate drug information.
- 32:34Speaker 6: Stay tuned.
- 32:35Speaker 4: We are coming out with episode four and it's going
- 32:38Speaker 4: to be a collaborative approach to medical information and how
- 32:42Speaker 4: involved and you as a pharmacist listening to this right now,
- 32:46Speaker 4: how involved you can become in building new drug information, reliable,
- 32:51Speaker 4: accessible reach out to the fact am I team, it's
- 32:54Speaker 4: fact m I, it's fact with a PHACTMIG work and hey,
- 33:01Speaker 4: thank you so much for everything you do for public health,
- 33:05Speaker 4: keeping our people safe throughout our nation. Evelyn, thank you
- 33:09Speaker 4: and thank you specifically for running this. This has been
- 33:13Speaker 4: incredible and special. Thanks to fact am I.
- 33:16Speaker 6: Thanks DoD